Progression of Diabetic Macular Edema: Correlation with Blood–Retinal Barrier Permeability, Retinal Thickness, and Retinal Vessel Diameter

2007 ◽  
Vol 48 (9) ◽  
pp. 3983 ◽  
Author(s):  
Birgit Sander ◽  
Dorte Nellemann Thornit ◽  
Lotte Colmorn ◽  
Charlotte Strøm ◽  
Aniz Girach ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Retinal Thickness ◽  
Retinal Vessel ◽  
Vessel Diameter ◽  
Blood Retinal Barrier ◽  
Barrier Permeability ◽  
Retinal Vessel Diameter

Diabetic Macular Edema

1998 ◽  
Vol 8 (3) ◽  
pp. 127-130 ◽  
Author(s):  
J. Cunha-Vaz
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Retinal Thickness ◽  
Vasogenic Edema ◽  
Retinal Disease ◽  
Retinal Edema ◽  
Blood Retinal Barrier ◽  
Retinal Tissue ◽  
First Case ◽  
Retinal Thickness Analyser

Retinal edema is defined as any increase of water in retinal tissue resulting in an increase in its volume. This increase may be initially intracellular or extracellular. In the first case, there is cytotoxic edema. In the second, vasogenic edema, directly associated with an alteration of the blood-retinal barrier (BRB). Retinal thickness can now be measured, using the retinal thickness analyser (RTA). Similarly, local breakdown of the BRB can now be mapped using the retinal leakage analyser (RLA). The application of these methods to diabetic macular edema has shown that both types of retinal retinopathy edema occur in the initial stages of diabetic retinal disease. These observations suggest a role for neuroprotective and vasoprotective agents in the management of diabetic retinal disease.

scholarly journals Effect of Ruboxistaurin on Blood–Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema

2005 ◽  
Vol 46 (10) ◽  
pp. 3855 ◽  
Author(s):  
Charlotte Strøm ◽  
Birgit Sander ◽  
Kristian Klemp ◽  
Lloyd Paul Aiello ◽  
Henrik Lund-Andersen ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Blood Retinal Barrier ◽  
Barrier Permeability

Short-Term Retinal Vessel Diameter Variability in Relation to the History of Cold Extremities

2006 ◽  
Vol 47 (9) ◽  
pp. 4026 ◽  
Author(s):  
Asan Kochkorov ◽  
Konstantin Gugleta ◽  
Claudia Zawinka ◽  
Robert Katamay ◽  
Josef Flammer ◽  
...  
Keyword(s):  
Retinal Vessel ◽  
Vessel Diameter ◽  
Short Term ◽  
Retinal Vessel Diameter ◽  
History Of ◽  
Cold Extremities

24-Hour variation of optical coherence tomography–measured retinal thickness in diabetic macular edema

2012 ◽  
Vol 22 (5) ◽  
pp. 785-791 ◽  
Author(s):  
Sokratis T. Kotsidis ◽  
Simeon S. Lake ◽  
Alexandros D. Alexandridis ◽  
Nikolaos G. Ziakas ◽  
Panagiotis K. Ekonomidis
Keyword(s):  
Optical Coherence Tomography ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Retinal Thickness ◽  
Optical Coherence

Diagnostic Ability of Retinal Vessel Diameter Measurements in Open-Angle Glaucoma

2015 ◽  
Vol 56 (13) ◽  
pp. 7915 ◽  
Author(s):  
Eunjoo Yoo ◽  
Chungkwon Yoo ◽  
Bo-ram Lee ◽  
Tae-Eun Lee ◽  
Yong Yeon Kim
Keyword(s):  
Open Angle Glaucoma ◽  
Retinal Vessel ◽  
Vessel Diameter ◽  
Open Angle ◽  
Diagnostic Ability ◽  
Retinal Vessel Diameter

scholarly journals Change In Retinal Vessel Diameter And Choroidal Thickness In Patients With Severe COVID-19

2021 ◽  
pp. 102674
Author(s):  
Medine Gündoğan ◽  
Esra Vural ◽  
Nurettin Bayram ◽  
Orhan Altunel ◽  
Fatih Gündoğan ◽  
...  
Keyword(s):  
Choroidal Thickness ◽  
Retinal Vessel ◽  
Vessel Diameter ◽  
Retinal Vessel Diameter

scholarly journals Comparing Objective Perimetry, Matrix Perimetry, and Regional Retinal Thickness in Mild Diabetic Macular Edema

2021 ◽  
Vol 10 (13) ◽  
pp. 32
Author(s):  
Bhim B. Rai ◽  
Ted Maddess ◽  
Corinne F. Carle ◽  
Emilie M. F. Rohan ◽  
Josh P. van Kleef ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Retinal Thickness ◽  
Objective Perimetry

scholarly journals Real-world outcomes of two-year Conbercept therapy for diabetic macular edema

2021 ◽  
Vol 14 (3) ◽  
pp. 416-422
Author(s):  
Yong Cheng ◽  
◽  
Ming-Wei Zhao ◽  
Tong Qian ◽  
◽  
...  
Keyword(s):  
Visual Acuity ◽  
Adverse Events ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Vision Loss ◽  
Retinal Thickness ◽  
Corrected Visual Acuity ◽  
The Mean ◽  
Number Of Injections ◽  
Best Corrected Visual Acuity

AIM: To evaluate the two-year outcomes of patients treated for diabetic macular edema (DME) with intravitreal Conbercept (IVC). METHODS: The clinical data of 30 DME patients (36 eyes) were retrospectively reviewed. The patients were treated with IVC for 3mo. Additional IVC was given at subsequent monthly visits, if needed (3+PRN). The patients were followed up for 24mo. RESULTS: The best-corrected visual acuity (BCVA) at 24mo significantly increased (66.7±15.3 letters) in comparison with the baseline (54.4±15.4 letters, P<0.0001). The mean improvement in BCVA was 11.0±2.9 letters. At 24mo, 44.1% of the eyes surveyed gained ≥15 letters, 52.9% of the eyes gained ≥10 letters, and 70.6% of the eyes gained ≥5 letters. No vision loss was noted in 96.8% of the eyes, and 5.9% of the eyes lost ≥5 letters, but ≤10 letters. The central retinal thickness (CRT) at 24mo was significantly reduced (277.1±122.9 μm) in comparison with the baseline (510.9±186.1 μm, P<0.0001). At 24mo, 43.3% of the patients had a CRT ≤250 μm. The mean number of injections over 24mo was 10.6±2.0. No severe eye or systemic adverse events related to either the drug or injection were noted. CONCLUSION: IVC is safe and effective for the treatment of DME.

Sign in / Sign up

Export Citation Format

Share Document